CARLOS
TAXONERA SAMSO
Profesor asociado de Ciencias de la Salud
Pharmacoeconomics and Outcomes Research Iberia
Pozuelo de Alarcón, EspañaPublications in collaboration with researchers from Pharmacoeconomics and Outcomes Research Iberia (2)
2022
-
Cost-effectiveness analysis of using innovative therapies for the management of moderate-to-severe ulcerative colitis in Spain
Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 22, Núm. 1, pp. 73-83
2009
-
Infliximab maintenance therapy is associated with decreases in direct resource use in patients with luminal or fistulizing crohn's disease
Journal of Clinical Gastroenterology, Vol. 43, Núm. 10, pp. 950-956